TECH WATCH

What is new in skincare technology.

Short briefs on devices, ingredients, AI and regulation. Every brief links to its source and carries an evidence rating, so you can tell what is proven from what is promised.

Sources last checked 18 Nov 2026.

Established
A regulator decision, human studies or a shipped product.
Emerging
Early studies, pilots or announcements.
Speculative
Lab-stage or marketing-led, with little human evidence.

In India

RegulationEstablishedAug 2026

Ad regulator: sun-care and de-tan ads top summer violations

The Advertising Standards Council of India reviewed 40 summer advertisements from April to June 2026. Twenty-one were modified or withdrawn without contest and 18 were found in violation. Sun protection and tan removal was the largest category, and claims such as de-tanning in 30 seconds had to be withdrawn or changed for lack of data.

Why it matters: Instant-result claims on de-tan and sun-care products are the ones most often failing substantiation in India. Look for stated test evidence, not speed promises.

Source: Advertising Standards Council of India (opens in a new tab) ↗

RegulationEstablished18 May 2026

Drug regulator: no cosmetic may be used as an injection

Business Today reported that in a public notice dated 18 May 2026 India’s Central Drugs Standard Control Organisation stated that products supplied in injectable form are not cosmetics, and that no cosmetic is permitted to be used as an injection by consumers, professionals or aesthetic clinics. It also said cosmetic labels and advertisements must not make misleading claims or claim to treat medical conditions.

Why it matters: Skin boosters and similar injectables offered as “cosmetic” fall outside cosmetics law. Skincare is what is applied to the surface; injections are procedures.

Source: Business Today (opens in a new tab) ↗

Sun protectionEstablished15 Apr 2026

India gets its first dedicated sunscreen standard

ChemLinked reports that the Bureau of Indian Standards issued IS 19685:2026, a specification for sunscreen cosmetic products, through a Gazette notification of 15 April 2026. It notes that India’s Cosmetics Rules, 2020 previously had no sunscreen-specific provisions on efficacy claims, labelling or standardised testing.

Why it matters: SPF and PA numbers on Indian sunscreens now have a national specification to be measured against, which should make labels easier to compare.

The standard has been issued. We could not confirm whether or when compliance becomes mandatory.

Source: ChemLinked (opens in a new tab) ↗

MarketEstablishedFeb 2026

Report: India’s beauty market about $23 billion, a fifth of it online

Redseer’s February 2026 report sizes India’s beauty and personal care market at about USD 23 billion in FY2025 and projects about USD 40 billion by FY2030. It puts e-commerce’s share at about 20% in FY2025, up from about 8% in FY2020, and projects 32–36% by FY2030.

Why it matters: One in five beauty rupees is already spent online, so more skincare is being chosen on a screen without a tester.

A consultancy estimate whose scope includes oral care, wellness and fragrance. The USD 40 billion figure is a 2030 projection, not today’s size.

Source: Redseer Strategy Consultants (opens in a new tab) ↗

AI & imagingEstablished18 Nov 2025

Nykaa launches a selfie-based skin scan in its app

On 18 November 2025 Nykaa launched Skin Scan, an in-app feature that analyses a selfie for up to 15 parameters, scores each from 1 to 100 and recommends products. Nykaa says the model was trained on more than 70,000 medically graded images.

Why it matters: India’s largest beauty retailer now steers product discovery with a face scan.

The feature has shipped, but the training figure is the company’s claim and we found no independent accuracy data. See the Which? test for how such scores can vary.

Source: MediaInfoline (opens in a new tab) ↗

RegulationEstablished14 Nov 2025

India notifies its data protection rules

A Press Information Bureau backgrounder dated 17 November 2025 says the Government notified the Digital Personal Data Protection Rules, 2025 on 14 November 2025, giving full effect to the 2023 Act with an eighteen-month phased compliance period. Organisations must give a separate, clear consent notice stating the specific purpose, tell people about a breach without delay, and answer access, correction and erasure requests within 90 days. Penalties run up to ₹250 crore.

Why it matters: Any app that takes a selfie for skin analysis must say plainly what the photo is used for and let you withdraw consent and ask for erasure. Expect clearer consent screens.

Source: Press Information Bureau, Government of India (opens in a new tab) ↗

AI & imagingEstablished6 Jun 2025

Indian skin image dataset released for AI research

DermaCon-IN, accepted at NeurIPS 2025, is a dataset of 5,450 clinical images from about 3,000 patients at outpatient clinics in South India, annotated with 245 diagnoses. It was first submitted to arXiv on 6 June 2025.

Why it matters: Most skin-imaging AI was trained mainly on lighter skin. India-sourced data is a precondition for tools that read Indian skin tones fairly.

This is a clinical research dataset, not a cosmetic one, and not a consumer product.

Source: arXiv (NeurIPS 2025 paper) (opens in a new tab) ↗

MarketEstablished22 Apr 2025

HUL completes its acquisition of 90.5% of Minimalist

Inc42 reported on 22 April 2025 that Hindustan Unilever completed the acquisition of 90.5% of Uprising Science Pvt Ltd, the parent of Minimalist, in an all-cash deal totalling ₹2,706.44 crore. The January 2025 agreement set a pre-money enterprise valuation of ₹2,955 crore.

Why it matters: An ingredient-transparent, online-first skincare brand now sits inside India’s largest consumer goods company, which should widen where it is sold.

The widely quoted ₹2,955 crore figure is the valuation, not the cash paid.

Source: Inc42 (opens in a new tab) ↗

Around the world

AI & imagingEstablished15 Oct 2026

Consumer test finds an AI skin analyser inconsistent

UK consumer body Which? reported on 15 October 2026 that it tested the Boots Skincare Diagnostic Tool with 30 people and more than 120 scans. About 63% got results matching their skin. Changing the lighting swung scores substantially for about half the group, and the tool under-read dark spots and struggled with hyperpigmentation on deeper skin tones. Boots told Which? the tool was no longer available online.

Why it matters: Selfie skin scores depend heavily on lighting and can under-read dark spots on deeper skin tones. Treat any scan, including ours, as a starting point for discovery and not a verdict.

An independent consumer test on a small group, not a peer-reviewed study.

Source: Which? (opens in a new tab) ↗

SustainabilityEstablished12 Aug 2026

EU packaging regulation applies from August 2026

The EU Packaging and Packaging Waste Regulation (EU) 2025/40 entered into force on 11 February 2025 and applies from 12 August 2026, according to the European Commission. Its aims include making all packaging on the EU market recyclable by 2030, more recycled plastic content, and reuse targets.

Why it matters: Beauty packaging sold in Europe will shift toward recyclable and refillable formats, and global brands tend to standardise packs across markets.

Source: European Commission, DG Environment (opens in a new tab) ↗

RegulationEstablished24 Jul 2026

EU delays high-risk AI rules; transparency duties stay on schedule

According to a Paul Weiss memo of 27 July 2026, the EU’s Digital Omnibus on AI was published on 24 July 2026. It moves compliance for high-risk systems listed in Annex III, the list that includes biometrics, to 2 December 2027. Transparency obligations under Article 50 took effect on 2 August 2026 as planned.

Why it matters: Face-scanning beauty tools sold in Europe face disclosure duties when certain AI systems analyse a person. Whether a given skin-analysis app falls into those categories is not settled in the sources we read.

A law-firm summary. No source we found addresses cosmetics apps specifically.

Source: Paul Weiss client memo (opens in a new tab) ↗

Longevity scienceSpeculative11 Jul 2026

PDRN serums: topical evidence is still very thin

Dermatology Times reviewed topical PDRN (“salmon DNA”) serums on 11 July 2026. It reports that a late-2025 study of a plant-derived PDRN is the first published topical clinical evidence for any form of PDRN, and notes that molecules of this size are unlikely to pass through intact skin. Injectable PDRN is not FDA-approved for cosmetic use.

Why it matters: Most PDRN research comes from injections, not creams. A serum may still feel hydrating, but the research does not yet show it reaches deeper skin layers.

Trade-press summary. We did not locate the underlying study.

Source: Dermatology Times (opens in a new tab) ↗

MicrobiomeEmerging25 Jun 2026

Ingredient maker reports a 3D map of facial skin microbes

On 25 June 2026 ingredient supplier dsm-firmenich announced a paper in press at the Journal of Investigative Dermatology describing a method that quantifies 26 bacterial and fungal species across 24 sites on the face.

Why it matters: Different zones of the face host different microbes, which may be part of why one product suits the forehead and not the cheeks.

A company announcement of a mapping method. It is not evidence that any “microbiome-friendly” product changes how skin looks.

Source: dsm-firmenich press release (opens in a new tab) ↗

Sun protectionEstablished9 Jun 2026

US FDA permits bemotrizinol, its first new sunscreen filter in decades

On 9 June 2026 the US FDA announced it had added bemotrizinol to the list of permitted over-the-counter sunscreen active ingredients, at up to 6%, for adults and children aged 6 months and older. The FDA described it as the first new active added to its sunscreen monograph since the late 1990s.

Why it matters: A filter long used in Europe and Asia can now appear in US-made sunscreens, which may mean lighter-feeling broad-spectrum formulas. Many sunscreens sold in India already use it.

Source: US FDA press announcement (opens in a new tab) ↗

Biotech ingredientsEmerging9 Apr 2026

BASF launches a yeast-fermented, human-identical collagen fragment

On 9 April 2026 BASF announced SkinNexus Collag3n, a recombinant collagen III fragment made by yeast fermentation with a human-identical sequence, developed with Bota Biosciences. BASF reports results from a laboratory skin model and from its own studies in women aged 53 to 70 over four weeks.

Why it matters: Animal-free collagen made by fermentation is entering mainstream ingredient catalogues, so expect to see it on labels.

The supporting data is company-run and BASF does not state sample sizes. Treat “collagen banking” claims as marketing until independent studies appear.

Source: BASF press release (opens in a new tab) ↗

RegulationEstablished12 Mar 2026

US cosmetics law: key rules still not finalised

A Foley & Lardner review dated 12 March 2026 reports that, as of January 2026, the FDA had issued neither final manufacturing-practice regulations nor fragrance allergen labelling rules under the Modernization of Cosmetics Regulation Act. As of 6 January 2026 the FDA’s system showed 14,299 active facility registrations and 992,907 active product listings.

Why it matters: US cosmetics are now registered and listed with the FDA, but allergen labelling and manufacturing standards that shoppers might assume exist were still pending.

Source: Foley & Lardner LLP (opens in a new tab) ↗

AI & imagingEmergingMar 2026

L’Oréal pilots a skin-protein test at the beauty counter

L’Oréal unveiled Cell BioPrint in January 2025, a lab-on-chip device built with Korean company NanoEnTek that analyses protein biomarkers from a cheek sample in about five minutes, alongside facial imaging and a questionnaire. L’Oréal says it launched with Lancôme as the pilot brand in March 2026.

Why it matters: Counter diagnostics are moving from photographs to measured skin proteins.

The claim that these scores predict how skin will look later is the company’s own. We found no independent validation.

Source: L’Oréal Groupe (opens in a new tab) ↗

PersonalisationEmergingJan 2026

Made-to-order cosmetics machine named a CES 2026 honoree

Korean contract manufacturer Cosmax’s maXpace was a CES 2026 Innovation Awards honoree in beauty tech. The listing describes an automated device that makes personalised skincare, foundation and lip products at the point of sale using swappable cartridges.

Why it matters: Formulas mixed on the spot to a shopper’s skin data are moving from concept to hardware that brands can buy.

The description is the company’s award entry. There is no evidence yet that bespoke blends perform better than well-chosen ready-made products.

Source: CES Innovation Awards (opens in a new tab) ↗

RegulationEstablished1 Nov 2025

EU retinol limits now apply to new cosmetic products

Under Regulation (EU) 2024/996, retinol and its esters are capped at 0.05% retinol equivalent in body lotions and 0.3% in other products. From 1 November 2025 non-compliant products can no longer be placed on the EU market, and products already on shelves have until 1 May 2027. Labels must warn that the product contains vitamin A.

Why it matters: Higher-strength retinol serums are being reformulated for Europe, so EU versions may differ from those sold elsewhere. The cap is about total vitamin A exposure; it is not a finding that retinol does not work on the look of skin.

Source: Obelis, summarising Regulation (EU) 2024/996 (opens in a new tab) ↗

DevicesEstablished15 Oct 2025

US FDA warns of injuries from radiofrequency microneedling

On 15 October 2025 the FDA issued a safety communication on radiofrequency microneedling, citing reports of burns, scarring, fat loss, disfigurement and nerve damage. The notice says these devices should not be used at home and advises using a licensed, trained provider.

Why it matters: Radiofrequency microneedling is sold as a skin-tightening treatment, and look-alike devices are sold online. The regulator treats it as a clinic procedure, not a home gadget.

Source: US FDA safety communication (opens in a new tab) ↗

Sensors & wearablesEmerging9 Apr 2025

Wearable measures gases passing through skin without touching it

Northwestern University researchers published in Nature on 9 April 2025 a device about 2 cm by 1.5 cm that measures water vapour, carbon dioxide and volatile compounds given off or absorbed by skin. It was tested in animals and humans. The team lists hydration tracking and evaluating lotions and cosmetics among possible uses; no commercial product was announced.

Why it matters: Water loss through the skin is how laboratories judge the skin barrier. A wearable could one day show whether a moisturiser holds water in during everyday life. Today it is a research tool.

Source: Northwestern University (paper in Nature) (opens in a new tab) ↗

DevicesEstablished5 Mar 2025

Pooled trials: at-home LED devices reduce blemishes

A systematic review and meta-analysis in JAMA Dermatology, published online on 5 March 2025, pooled 6 randomised trials with 216 participants aged 12 to 50. Compared with controls, at-home red and/or blue LED devices gave larger reductions in blemish counts, with no severe adverse reactions. The authors noted that the trials varied a lot and that larger studies are needed.

Why it matters: This is the strongest pooled evidence for home LED masks, and it covers blemish-prone skin only.

LED masks are widely sold for firmness and lines. This analysis does not cover those claims, and it rests on 216 people.

Source: JAMA Dermatology (opens in a new tab) ↗

Longevity scienceEstablished6 Dec 2019

No exosome product is FDA-approved

The US FDA’s public safety notification on exosome products states that there are currently no FDA-approved exosome products. The notice dates from 6 December 2019 and remains on the FDA site.

Why it matters: “Exosome” on a serum label is a cosmetic ingredient claim, not one a regulator has reviewed.

The regulatory status is established. Any benefit from exosomes applied to the skin surface remains speculative.

Source: US FDA (opens in a new tab) ↗

Briefs summarise the linked source and are not endorsements. A technology being new does not mean it works; check the evidence rating. Nothing here is medical advice. Spotted an error? Tell us through Ask The Skinverse.